Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand diseaseAJOG Global Reports at a Glance

Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand diseaseAJOG Global Reports at a Glance

Background: Heavy menstrual bleeding is the dominant symptom in girls/women with von Willebrand disease (VWD), affecting ∼80 to 90%. Female patients with VWD are typically diagnosed later than males, despite the disproportionate impact of heavy menstrual bleeding. Although heavy menstrual bleeding h...

Full description

Saved in:
Bibliographic Details
Main Authors: Csongor Kiss, Zoltan Boda, Claudia Djambas Khayat, Ana Boban, Leonid Dubey, Robert F. Sidonio Jr
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:AJOG Global Reports
Subjects:
clinical trial
women’s health
bleeding and clotting
inherited bleeding disorder
replacement therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2666577825000620
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

http://www.sciencedirect.com/science/article/pii/S2666577825000620

Similar Items